Life sciences Archives

Subscribe to the Life sciences RSS feed.

CEO Peer Survey, August 2009 — Preparing for Recovery?

istock_000005846970xsmall

Below is the hyperlink to our latest CEO peers “speed-survey,” exclusively for growth-stage CEOs.  Topic– “Preparing for Recovery?”

http://surveys.polldaddy.com/s/D3642F14267CCC14/

We at BSG Team Ventures periodically take the temperature of the markets we serve. This speed survey is no more than 10 questions, simple multiple-choice.

Knowledge is power.  Aggregated peer-provided knowledge is “actionable power.”

We make an effort to survey only those who fit the category (in this case, sitting CEOs or board member/founders of technology/science-driven growth-stage companies). [Note, if you don't fit the aforementioned description, please refrain from responding.]

Feel free to forward to the qualified CEOs in your sphere of influence.  The more data generated, the more accurate the trend lines.

All responses are anonymous due to the web-based survey technology employed.

We will forward the survey results within the next two weeks to the email address on file.  Please let us know if there is another email address you wish us to send the results to as well.

General Manager: eTrinsic Division

Untitled Document

Position: General Manager, Simbionix eLearning

Reports to: CEO, Simbionix USA

Location: Denver, CO

Website: www.simbionix.com

“Virtual reality simulation in surgical training has become more widely used and intensely investigated in an effort to develop safer, more efficient, measurable training processes…If executed properly, virtual reality offers inherent advantages over other training systems in creating a realistic surgical environment and facilitating measurement of surgeon performance.”E. Seymour and J.S. Rotnes, Surgical Endoscopy (2007)

“If we’re going to make a mistake, let’s make it on the simulators first.” - Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center, Rochester, NY, on why physicians are eager to start using the new Simbionix PROcedure Studio simulator

“If the learning actually matters, use simulations. If it doesn’t, don’t worry about it.” - Clark Aldrich, founder of SimuLearn, industry visionary, and author of numerous articles and books on simulations and e-learning

SIMBIONIX IN THE NEWS

http://www.simbionix.com/News.html

http://www.simbionix.com/PROcedure.html

THE COMPANY

Surgical simulators have been developed in the past few years to enhance the training of physicians, reduce the number of animals and cadavers, and provide flexible training scenarios and preoperative planning. Despite their potential benefits, and the fact that they have precedence in flight simulators, there are very few simulators in current use globally. Simbionix as a leadership company in this growing industry is changing the medical training landscape.

As a world leader in the field of medical education and simulation technology, Simbionix offers the most comprehensive medical training experience available, using the latest software and hardware technology. The company’s state-of-the-art technology provides surgeons, interventionists, nurses, and technicians with a robust platform to learn and master critical skills to ensure procedural efficiency and promote quality patient outcomes. The systems offer a range of basic and highly advanced procedures, and incorporate detailed and complete metrics for skill assessment.

The user is free to practice skills and perform procedures until the required proficiency is attained. In addition, difficult and uncommon procedures may be practiced at any time. This maximizes consistency to optimize learning, providing a clear advantage over relying solely on previous ly available patient training methods. More…

More on VC-backed CEO Survey asking about “Recession-Proofing” for 2009

Here is the balance of the survey responses from the VC-backed CEO survey we administered at the end of December 2008 into the first week of January 2009, both responses and a bit of interpretation.

Given survey responses, it appears the bell curve peak is in the 20-40% reduction in headcount.  The group of CEOs who indicated these reductions were approximately half of the 60 CEO respondents.

  • •    40% or more staff reductions? ~ 10% of total CEOs surveyed
  • •    Less than 20% staff reductions? ~ About 17% of all CEO respondents

Winner on this question was “more than 9 months,” with more than 40% of the CEOs.  Runners-up were the “0-to-6 months of cash” CEOs, evenly split with 25% saying 3 to 6 months, and another 25% saying “less than 3 months.”  What this may indicate is that there is a bimodal distribution of funding in the market –those who are well-funded, with 9 months or more, and those companies who are running out of cash (popular definition = less than 6 months of cash remaining).  This is reinforced by the fact that very few companies responded that they had 7-9 months of cash (less than 10% of companies).  Therefore, one might imagine that those companies who are shortest on cash are also those who are making the deepest cuts in staffing.  In addition, that there may be another round of cuts in store for those low-cash companies if they can’t get another round closed soon.

Top implied answer here?   Don’t raise a venture round in 2009.  And this is what the largest slug of CEOs responded with (33%).  Of those who are going to try to raise in 2009,

  • •    one-third of CEOs see a flat round
  • •    16% feel they’ll get an up round
  • •    and almost half (45%) are predicting a down round

Winner for this question shows some great optimism however, with about 1/3 each of the CEOs responding answering with either “revenues up 1 to 25%”  or “Up more than 50%.”

There was an intentional effort to get a fairly even distribution of venture-backed CEO respondents for this survey, to try to avoid sector bias.  We were fortunate to have at least 10% (6 or more companies) from each of life sciences / biotech, medical devices, and the cleantech sectors.  Software/Internet/telecom was the largest category represented, with 42% of CEOs hailing from this sector.

BONUS SLIDE

Q: If YOU could survey your peer CEOs, what question(s) are both urgent AND important to running your business you’d like us to consider asking in future polls?

This was one of the most rewarding questions for which to see the responses.  Fully half of the CEOs polled had a question they’d like to pose to their peers, and some CEOs had several.  Below is a partial list of questions we’ll choose from in follow-on surveys.  If any of those CEOs would like to respond individually to any of the questions below, feel free to post a comment on this blog entry and we’ll post it for public consumption (clustered by general question subcategory as well as by industry sector).  Of course, the winning question asked by one of you CEOs, just to validate that venture capital-backed CEOs are-if anything-self-aware, pragmatic, and not fatally over-optimistic:

“What will CEOs do if their company fails?!”
1.   Cost-related questions

  • •    Approaches or success stories in restructuring debt to the company’s advantage.
  • •    Is it better to reduce headcount 20%, go to a 4-day work week, or reduce salaries by 20%?
  • •    In addition to headcount reductions (if any), what type of expenses are you reducing?  Are you delaying new projects/initiatives?  How have investors reacted to this?
  • •    Will you consider outsourcing some of your product development to make cost variable, at the expense of some know-how then being outside the company?

2.    Sales/Marketing/Revenue-related questions

  • •    How are you using the economic downturn to improve your business position/model?
  • •    What are you going to spend more money on in 2009 than in 2008?
  • •    What changes in the sales cycle are you seeing in the last 6months, 2 months, currently?  What does the resultant trend point to for 2009 and what actions are you taking in response?
  • •    How has your visibility into the level of future business changed in the last 3-6 months?Asked another way – what level of confidence do you have in your current forecast of business?
  • •    (1) What emphasis do you place on marketing in your organization? (2) What do you consider the top 3 most important elements of marketing to be?
  • •    How will you as CEO deal with longer term rate issues if you are a service business as it seems all labor rates are being pushed down?
  • •    The number one reason why clients buy your product is? (cost, quality, service, other?)

3.    Funding/exit/valuation questions

  • •    Are you finding lending lines out there?
  • •    If an acquirer made an offer to buy your company today, but at a multiple less than what it would be in a strong economy, would you consider it, or wait until the economy improves so you could get a higher valuation?
  • •    Are you considering merging your company with another? Are you looking at merger partners as a legitimate exit option in 2009?
  • •    Are you looking to current investors or new investors for additional rounds of financing?

4.    Board of Directors/investor-related questions

  • •    How will venture capital investing change in 2009?
  • •    What is your satisfaction with your Board’s ability to fundraise in the future? (I think the current environment highlights a board’s function as protector of value through fundraising and too few board members are good at it)?
  • •    Compensation for outside board members?

5.    Staffing/talent questions

  • •    How are you balancing full time versus contract employees?
  • •    How are you retaining employees during these tough times?
  • •    What kind of retention ideas have you considered to make sure your key folks don’t bail for a more stable environment?
  • •    What skills are you as CEO still looking to hire?
  • •    What do you do to conserve cash? attract customers?
  • •    How many of you CEOs have proposed reducing people to part time levels and adding equity compensation instead of releasing them all together?

6.    Economy-related questions

  • •    When do you predict the market conditions to take a turn for the better?

There a few industry-specific questions CEOs wanted to ask their peer as well:

Life sciences/biotech-related questions

  • •    What kind of deal structures are you seeing in liquidity-directed partnerships? What kind of partnerships, if any, are you envisioning for discovery stage assets?

Medical devices-related questions

  • •    How do you expect reimbursement to be influenced during the next administration?